Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...

A panelist discusses how the historical standard of care for metastatic squamous cell anal carcinoma evolved from ...

A panelist discusses how squamous cell cancer of the anal canal has nearly doubled in incidence over 30 years, with human ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Employers are key to transforming healthcare by creating competitive, cost-effective networks independent of federal policy ...

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

As sweeping policy shifts and rising restrictions threaten LGBTQ+ health access, providers, payers and employers reflect on what’s at stake in Pride Month's end—and what it will take to protect ...

The letter, signed by 79 medical societies, expresses concern over recent federal immunization review policies and asks that ...

A new study finds that enrollees who had difficulty accessing care in Medicare Advantage plans were more likely to switch to ...

While drug prices and insurance companies often draw scrutiny, the report shifts the spotlight to hospitals—particularly ...

More than 50 insurers have pledged to streamline and simplify the prior authorization process through six new commitments.